Compare NeoGenomics Inc. Common Stock (NEO) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? NeoGenomics Inc. Common Stock trades at $16.84 (market cap $2.17B), while First Trust NASDAQ 100 Technology Index Fund trades at $307.85 (market cap $4.70B). The key difference: First Trust NASDAQ 100 Technology Index Fund is far larger — about 2.2× NeoGenomics Inc. Common Stock's market cap, and First Trust NASDAQ 100 Technology Index Fund is more actively traded (257,463 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and First Trust NASDAQ 100 Technology Index Fund for 40 Days on average.
| NEO | QTEC | |
|---|---|---|
Market Cap | $2.17B | $4.70B |
Volume | 1,615,943 | 257,463 |
Sector | Health | Broad Market / Factor |
52-Week High | $19.91 | $340.28 |
52-Week Low | $7.19 | $207.03 |
Typical Hold Time | 0 Days | 40 Days |
Enterprise Value | $2.47B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $324.27, down 0.59% on the day. The technical outlook is bullish based on moving averages, with key support at $321 and resistance at $335. Recent analysis highlights its equal-weighted exposure to the technology sector and better liquidity compared to peers.
The ETF offers broad tech exposure but faces sector-specific volatility risks. Upside potential hinges on technology sector performance, while downside risks include macroeconomic pressures on growth stocks. Investor sentiment remains mixed with a neutral oscillator reading.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →
